CO53 Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study

Autor: Chauhan, A., Samnaliev, M., Ken-Opurum, J., Sai Srinivas, S., Mehta, A.M., Dex, T., Charland, S., Revel, A., Preblick, R.
Zdroj: In Value in Health June 2023 26(6) Supplement:S24-S24
Databáze: ScienceDirect
Externí odkaz: